Michael Bös

3.5k total citations
43 papers, 1.8k citations indexed

About

Michael Bös is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Michael Bös has authored 43 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 16 papers in Cellular and Molecular Neuroscience and 14 papers in Organic Chemistry. Recurrent topics in Michael Bös's work include Receptor Mechanisms and Signaling (13 papers), Neurotransmitter Receptor Influence on Behavior (10 papers) and Hepatitis C virus research (10 papers). Michael Bös is often cited by papers focused on Receptor Mechanisms and Signaling (13 papers), Neurotransmitter Receptor Influence on Behavior (10 papers) and Hepatitis C virus research (10 papers). Michael Bös collaborates with scholars based in Switzerland, Canada and Austria. Michael Bös's co-authors include Andrew J. Sleight, Claus Riemer, Anne Bourson, Frank Boess, James R. Martin, F. Jenck, Bernard Levet‐Trafit, Jean‐Luc Moreau, J. Wichmann and Joel R. Martin and has published in prestigious journals such as Annals of the New York Academy of Sciences, Journal of Medicinal Chemistry and Journal of Hepatology.

In The Last Decade

Michael Bös

42 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Bös Switzerland 21 890 858 536 204 201 43 1.8k
Mark H. Norman United States 30 918 1.0× 559 0.7× 1.0k 1.9× 160 0.8× 60 0.3× 65 3.1k
Akio Kanatani Japan 34 1.3k 1.4× 1.2k 1.4× 241 0.4× 178 0.9× 74 0.4× 85 3.7k
John E. Starrett United States 20 708 0.8× 321 0.4× 665 1.2× 75 0.4× 21 0.1× 38 1.5k
Dilip K. Tosh United States 28 1.4k 1.6× 538 0.6× 452 0.8× 129 0.6× 15 0.1× 96 2.5k
Angus M. MacLeod United Kingdom 27 1.1k 1.2× 912 1.1× 893 1.7× 100 0.5× 10 0.0× 62 2.4k
Hisashi Iwaasa Japan 26 728 0.8× 578 0.7× 204 0.4× 80 0.4× 57 0.3× 55 2.1k
Benjamin G. Tehan Australia 17 1.1k 1.2× 572 0.7× 212 0.4× 37 0.2× 87 0.4× 28 1.5k
Ian T. Forbes United Kingdom 26 1.3k 1.4× 1.3k 1.6× 663 1.2× 195 1.0× 12 0.1× 59 2.6k
Laurence R. Meyerson United States 23 650 0.7× 775 0.9× 172 0.3× 212 1.0× 5 0.0× 56 1.5k
María Novella Romanelli Italy 27 1.6k 1.8× 587 0.7× 674 1.3× 464 2.3× 5 0.0× 170 2.6k

Countries citing papers authored by Michael Bös

Since Specialization
Citations

This map shows the geographic impact of Michael Bös's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Bös with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Bös more than expected).

Fields of papers citing papers by Michael Bös

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Bös. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Bös. The network helps show where Michael Bös may publish in the future.

Co-authorship network of co-authors of Michael Bös

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Bös. A scholar is included among the top collaborators of Michael Bös based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Bös. Michael Bös is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Müller, Marcus, Michael Bös, Michael Burnet, et al.. (2022). A potassium channel agonist protects hearing function and promotes outer hair cell survival in a mouse model for age-related hearing loss. Cell Death and Disease. 13(7). 595–595. 11 indexed citations
2.
Beaulieu, Pierre L., Michael Bös, Michael G. Cordingley, et al.. (2012). Discovery of the First Thumb Pocket 1 NS5B Polymerase Inhibitor (BILB 1941) with Demonstrated Antiviral Activity in Patients Chronically Infected with Genotype 1 Hepatitis C Virus (HCV). Journal of Medicinal Chemistry. 55(17). 7650–7666. 36 indexed citations
3.
White, Peter W., Montse Llinàs‐Brunet, & Michael Bös. (2006). 2 Blunting the Swiss Army Knife of Hepatitis C Virus: Inhibitors of NS3/4A Protease. Progress in medicinal chemistry. 44. 65–107. 9 indexed citations
4.
Hoffmann, Torsten, Michael Bös, Heinz Stadler, et al.. (2005). Design and synthesis of a novel, achiral class of highly potent and selective, orally active neurokinin-1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 16(5). 1362–1365. 34 indexed citations
5.
O’Meara, Jeff A., Christiane Yoakim, Pierre Bonneau, et al.. (2005). Novel 8-Substituted Dipyridodiazepinone Inhibitors with a Broad-Spectrum of Activity against HIV-1 Strains Resistant to Non-nucleoside Reverse Transcriptase Inhibitors. Journal of Medicinal Chemistry. 48(17). 5580–5588. 15 indexed citations
6.
Beaulieu, Pierre L., Michael Bös, Yves Bousquet, et al.. (2003). Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery and preliminary SAR of benzimidazole derivatives. Bioorganic & Medicinal Chemistry Letters. 14(1). 119–124. 82 indexed citations
7.
Yoakim, Christiane, Pierre Bonneau, Robert Déziel, et al.. (2003). Novel nevirapine-like inhibitors with improved activity against NNRTI-resistant HIV: 8-heteroarylthiomethyldipyridodiazepinone derivatives. Bioorganic & Medicinal Chemistry Letters. 14(3). 739–742. 22 indexed citations
8.
Bös, Michael, Andrew J. Sleight, Thierry Godel, et al.. (2001). 5-HT6 receptor antagonists: lead optimisation and biological evaluation of N-aryl and N-heteroaryl 4-amino-benzene sulfonamides. European Journal of Medicinal Chemistry. 36(2). 165–178. 40 indexed citations
9.
Sleight, Andrew J., Frank Boess, Michael Bös, & Anne Bourson. (1998). The Putative 5‐ht6 Receptor: Localization and Function. Annals of the New York Academy of Sciences. 861(1). 91–96. 34 indexed citations
10.
Sleight, Andrew J., Frank Boess, Michael Bös, et al.. (1998). Characterization of Ro 04‐6790 and Ro 63‐0563: potent and selective antagonists at human and rat 5‐HT6 receptors. British Journal of Pharmacology. 124(3). 556–562. 150 indexed citations
11.
Albertini, Silvio, Michael Bös, Elmar Gocke, et al.. (1998). Suppression of mutagenic activity of a series of 5HT2C receptor agonists by the incorporation of a gem-dimethyl group: SAR using the Ames test and a DNA unwinding assay. Mutagenesis. 13(4). 397–403. 10 indexed citations
12.
Bourson, Anne, Frank Boess, Michael Bös, & Andrew J. Sleight. (1998). Involvement of 5‐HT6 receptors in nigro‐striatal function in rodents. British Journal of Pharmacology. 125(7). 1562–1566. 71 indexed citations
13.
Martin, Joel R., Michael Bös, F. Jenck, et al.. (1998). 5-HT2C Receptor Agonists: Pharmacological Characteristics and Therapeutic Potential. Journal of Pharmacology and Experimental Therapeutics. 286(2). 913–924. 283 indexed citations
14.
15.
Bös, Michael, et al.. (1997). O-Methylasparvenone, a nitrogen-free serotonin antagonist. Bioorganic & Medicinal Chemistry. 5(12). 2165–2171. 22 indexed citations
16.
17.
Bös, Michael. (1991). Optionsbewertung und Kapitalmarkt. 1 indexed citations
18.
Bös, Michael, Willy P. Burkard, Jean‐Luc Moreau, & Peter Schönholzer. (1990). Synthesis of rel‐(3RS,3aSR,7aSR)‐3‐(4‐Chlorophenyl)‐3a,4,5,6,7,7a‐hexahydro‐1‐methylindolin‐6‐one, the Main Metabolite of the Analgesic Ro 15‐8081: A Potent Amine‐Uptake Inhibitor. Helvetica Chimica Acta. 73(4). 932–939. 3 indexed citations
19.
Bös, Michael & Wilhelm Fleischhacker. (1984). Sydnone und Sydnonimine Chemie und Pharmakologie. Pharmazie in unserer Zeit. 13(2). 51–56. 6 indexed citations
20.
Bös, Michael & Wilhelm Fleischhacker. (1981). Lichtinduzierte Reaktionen an Morphinderivaten, 1. Etherbrückenphotolyse an 7,14‐Cyclodihydrocodeinon. Liebigs Annalen der Chemie. 1981(11). 1994–2001. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark H. Norman Breakdown of academic impact, for papers by Akio Kanatani Breakdown of academic impact, for papers by John E. Starrett Breakdown of academic impact, for papers by Dilip K. Tosh Breakdown of academic impact, for papers by Angus M. MacLeod Breakdown of academic impact, for papers by Hisashi Iwaasa Breakdown of academic impact, for papers by Benjamin G. Tehan Breakdown of academic impact, for papers by Ian T. Forbes Breakdown of academic impact, for papers by Laurence R. Meyerson Breakdown of academic impact, for papers by María Novella Romanelli
Rankless by CCL
2026